Heidrun Mitzel-Rink

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

Uğur Şahin, Petra Oehm, Evelyna Derhovanessian et al. · Nature · 2020 · 961 citations

Checkpoint-inhibitor-treated Melanoma, Melanoma, Immunology +5

Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors

Alvaro Moreira, Carmen Loquai, Claudia Pföhler et al. · European Journal of Cancer · 2018 · 226 citations

Autoimmune Disease, Immune Checkpoint Inhibitors, Immune Regulation +6

Effects of structured patient education in adults with atopic dermatitis: Multicenter randomized controlled trial

Annice Heratizadeh, Thomas Werfel, Andreas Wollenberg et al. · Journal of Allergy and Clinical Immunology · 2017 · 125 citations

Family Medicine, Health Policy, Structured Patient Education +7

Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

Jürgen C. Becker, Selma Ugurel, Ulrike Leiter et al. · The Lancet · 2023 · 63 citations

Tumor Immunology, Surgical Oncology, Nivolumab Versus Observation +10

The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study

Julia K. Tietze, Andrea Forschner, Carmen Loquai et al. · Oncotarget · 2018 · 35 citations · Full text

Tumor Biology, Oncology, Skin Cancer +15